Author + information
- Received June 28, 1994
- Revision received October 18, 1994
- Accepted October 20, 1994
- Published online March 1, 1995.
- Anatoly Langer, MD, FACC*,
- Michael R. Freeman, MD, FACC,
- Robert G. Josse, MD and
- Paul W. Armstrong, MD, FACC
- ↵*Address for correspondence: Dr. Anatoly Langer, St. Michael's Hospital, 30 Bond Street, Suite 701A, Toronto, Ontario M5B 1W8, Canada.
Objectives. This study in patients with diabetes mellitus was undertaken 1) to evaluate cardiac sympathetic innervation in diabetic patients using metaiodobenzylguanidine (MIBG) imaging; 2) to study the relation between autonomic function assessed by clinical maneuvers and abnormalities in MIBG uptake; and 3) to examine the basis for our previous observation of an association between abnormalities in autonomic nervous system dysfunction and silent myocardial ischemia.
Background. The clinical detection of autonomic dysfunction in diabetes mellitus has been linked to both abnormal perception of pain, including angina, and poor prognosis.
Methods. Uptake of MIBG was measured by dual-isotope imaging in 23 normal subjects and 65 asymptomatic diabetic patients. Silent myocardial ischemia was defined as the presence of a reversible perfusion defect in patients with ST segment depression.
Results. The MIBG uptake in the diabetic patients was significantly lower than that in normal subjects in the apex (67 ± 17% vs. 82 ± 7%, p = 0.0001), distal third (77 ± 11% vs. 85 ± 3%, p = 0.0001), proximal third (77 ± 9% vs. 84 ± 3%, p = 0.0001) and base (71 ± 9% vs. 80 ± 4%, p = 0.0001) of the left ventricle. Similarly, MIBG uptake was variable across different vascular territories. When MIBG uptake was corrected for perfusion abnormalities, diabetic patients had a greater MIBG uptake defect than normal subjects on visual score assessment (16 ± 13 vs. 8 ± 7%, p = 0.0002) and on quantitative MIBG mismatch assessment (13 ± 15% vs. 2 ± 2%, p = 0.0001). Diabetic patients with versus without autonomic dysfunction had more extensive MIBG uptake mismatch (17 ± 17% vs. 4 ± 6%, p = 0.0001). There was a greater diffuse abnormality in diabetic patients with versus without silent myocardial ischemia detected by sestamibi/MIBG uptake ratio (68 ± 35% vs. 19 ± 33%, p = 0.001).
Conclusions. Sympathetic cardiac innervation in normal subjects is inhomogeneous. In contrast to normal subjects, diabetic patients have evidence of a significant reduction in MIBG uptake, most likely on the basis of autonomic dysfunction. Furthermore, diabetic patients with silent myocardial ischemia have evidence of a diffuse abnormality in MIBG uptake, suggesting that abnormalities in pain perception may be linked to sympathetic denervation.
This study was supported in part by the Canadian Diabetes Association, Toronto, Ontario, Canada.
- Received June 28, 1994.
- Revision received October 18, 1994.
- Accepted October 20, 1994.
- American College of Cardiology